Jun. 30, 2015

HARRISBURG – House Judiciary Committee Majority Chairman Ron Marsico (R-Dauphin), Rep. Mike Regan (R-York/Cumberland) and Rep. Sheryl Delozier (R-Cumberland) are pleased to introduce legislation that would permit the use of medical cannabis in Pennsylvania in a controlled fashion.

“All three prime sponsors of this bill, myself included, are extremely passionate about this issue and wanted to share the responsibility that sponsoring this bill carries. I am confident that together, we can not only garner support for the legislation but also be available to discuss it with other members and answer any questions they may have,” said Marsico.

House Bill 1432 would permit the use of medical cannabis within the Commonwealth. Based on information learned during the committee’s hearings and statutes enacted in other states, this legislation would:

• Establish a medical cannabis program to be administered by the Department of Drug and Alcohol Programs.

• Permit a doctor of medicine or doctor of osteopathy to certify that a patient may use medical cannabis if they are suffering from a serious medical condition. A serious medical condition includes cancer, HIV/AIDS, amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis, damage to the nervous tissue of the spinal cord, epilepsy, inflammatory bowel disease, neuropathies and Huntington’s disease.

• Authorize the department to issue counterfeit-proof identification cards to patients and caregivers who may then go to a dispensary owned by a medical cannabis organization to obtain medical cannabis.

• Authorize the department to register as many as five medical cannabis organizations. A medical cannabis organization will grow, process, distribute and sell medical cannabis. Each medical cannabis organization may operate no more than four dispensaries, which are to be wholly owned and operated by the medical cannabis organization. The dispensaries must be geographically disbursed throughout the Commonwealth.

• Establish an excise tax to apply to the sale of medical cannabis, to be paid by medical cannabis organizations. The tax may not be passed onto the patient or caregiver.

• Provide that all fees and taxes be deposited into a Medical Cannabis Program Fund established in the State Treasury. The fund will pay the cost of running the program, as well as for medical research related to the safety and use of medical cannabis. It will also provide grants to district attorneys’ offices, municipal police departments and the Pennsylvania State Police through the Pennsylvania Commission on Crime and Delinquency and pay for drug and alcohol abuse programs within the Commonwealth.

• Establish criminal penalties for diversion of medical cannabis, the falsification of identification cards and the adulteration of medical cannabis.

• Clarify that no patient, caregiver, medical cannabis organization, or practitioner shall be subject to arrest or penalty or denied any right or privilege for lawful use of medical cannabis.

• Allow medical cannabis to be administered through vaporization or in oil or pill form. Smoking and edibles will be prohibited. Strict limits and testing requirements will apply to the amounts of tetrahydrocannabinol and cannabidiol, which must be disclosed through plain labeling of medical cannabis products. The bill provides a process for the recall of defective or inaccurately labeled medical cannabis.

• Require medical cannabis organizations to adopt and maintain security, tracking, recording-keeping and surveillance systems related to medical cannabis. It also requires real-time inventory tracking from seed-to-sale.

• Charge the department with the responsibility of providing a written report every two years describing the implementation of the act, an assessment of the benefits and risks to patients receiving medical cannabis, and any recommendations for amendments to the law.

“As a mother, I cannot even imagine the anguish of watching one of my children suffer from a debilitating and painful disease such as MS or cancer and being powerless to help them. Imagine a doctor telling a mother that their child could get relief from their pain with medical cannabis, but they can’t because they live in Pennsylvania,” said Delozier.

“This legislation is a different approach than what has been offered so far in Pennsylvania. We know that not everyone will be pleased with this approach. It will be too narrow for some, and too expansive for others. But we feel that this measure allows us to build a real consensus in the legislature and start a medical cannabis program in Pennsylvania. If successfully implemented, the program can be expanded or contracted in the future, to adjust for changing medical knowledge and public comfort in allowing safe medical cannabis access,” said Marsico. “We believe that Senate Bill 3, while motivated by genuine compassion, is not satisfactory legislation for some and does not go far enough towards implementing a responsible, narrow, regulated piece of legislation that allows the medical use of medical cannabis while taking special precautions against abuse or diversion of cannabis for non-medical purposes.”

This legislation truly provides a good middle ground and is truly compromise legislation. We believe it will allow us to safely implement the use of medical cannabis in this state. The language has been carefully drafted to ensure smooth implementation and reach our goal of helping those who so desperately need it.

“I believe that it is imperative that we pass legislation which allows for the use of medical cannabis in Pennsylvania. It is important that we show compassion to those who suffer from a number of illnesses. Doctors should have access to all medicines available, which may help relieve debilitating sickness and pain,” said Regan.

House Bill 1432 has not yet been assigned to a committee.

Representative Ronald Marsico
105th District
Pennsylvania House of Representatives
Media Contact: Autumn R. Southard, 717.652.3721